DriveThru Urgent Care rendering
DriveThru Urgent Care launches game-changing approach to help patients get better faster
20 juin 2023 11h35 HE | Viral Solutions LLC
ATLANTA, June 20, 2023 (GLOBE NEWSWIRE) -- This summer, DriveThru Urgent Care — by Viral Solutions — will usher in a groundbreaking era of healthcare by treating patients with time-sensitive medical...
Rodale Institute to
Rodale Institute to Host Immersive Conference Addressing How to Launch a Farm-to-Institution Program
12 juin 2023 10h27 HE | Rodale Institute
KUTZTOWN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Rodale Institute’s 2023 Farm-to-Healthcare Immersion conference will provide step-by-step guidance on how leaders can create a successful...
Picture3.jpg
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
09 juin 2023 09h30 HE | Clearmind Medicine Inc.
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, June 09, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
OpGen.jpg
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
26 avr. 2023 16h30 HE | OpGen, Inc.
Triggers milestone payment of approximately $0.3 million ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biosimulation Market to Reach a Capital Expenditure of USD 10.1 in 2032 | CAGR of 13.7%
25 avr. 2023 14h37 HE | Market.Us
New York, April 25, 2023 (GLOBE NEWSWIRE) -- As per the latest finding of Market.us, Biosimulation Market Revenue is expected to be USD 2.9 by the end of 2022. In the long term, the market is...
Picture3.jpg
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
21 avr. 2023 08h30 HE | Clearmind Medicine Inc.
The application is for a novel psychedelic-based combination, of Clearmind's MEAI and SciSparc's Cannamide™ Tel Aviv, Israel / Vancouver, Canada, April 21, 2023 (GLOBE NEWSWIRE) --...
visiongain Logo.png
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd
05 avr. 2023 07h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Regenerative Medicine Market 2023-2033. It includes profiles of Regenerative Medicine Market and Forecasts, Regenerative Medicine Market Size By Product...
Agilis Consulting Group
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
24 mars 2023 10h40 HE | Kymanox
Morrisville, North Carolina USA, and Cincinnati, Ohio USA, March 24, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the life science...
visiongain Logo.png
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd
13 mars 2023 07h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Regenerative Medicine Market 2023-2033. It includes profiles of Regenerative Medicine Market and Forecasts, Regenerative Medicine Market Size By Product...
Rapid Micro Biosystems logo
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
03 mars 2023 07h00 HE | Rapid Micro Biosystems, Inc.
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million,...